Literature DB >> 34710382

A Novel Mouse Model of Nonalcoholic Steatohepatitis Suggests that Liver Fibrosis Initiates around Lipid-Laden Macrophages.

Mayuko Ichimura-Shimizu1, Yosuke Tsuchiyama2, Yuki Morimoto2, Minoru Matsumoto3, Tomoko Kobayashi2, Satoshi Sumida2, Takumi Kakimoto2, Takeshi Oya3, Hirohisa Ogawa2, Michiko Yamashita4, Satoru Matsuda5, Katsuhisa Omagari6, Shu Taira7, Koichi Tsuneyama8.   

Abstract

While the interaction of cells such as macrophages and hepatic stellate cells is known to be involved in the generation of fibrosis in nonalcoholic steatohepatitis (NASH), the mechanism remains unclear. This study employed a high-fat/cholesterol/cholate (HFCC) diet to generate a model of NASH-related fibrosis to investigate the pathogenesis of fibrosis. Two mouse strains: C57BL/6J, the one susceptible to obesity, and A/J, the one relatively resistant to obesity, developed hepatic histologic features of NASH, including fat deposition, intralobular inflammation, hepatocyte ballooning, and fibrosis, after 9 weeks of HFCC diet. The severity of hepatic inflammation and fibrosis was greater in A/J mice than in the C57BL/6J mice. A/J mice fed HFCC diet exhibited characteristic CD204-positive lipid-laden macrophage aggregation in hepatic parenchyma. Polarized light was used to visualize the Maltese cross, cholesterol crystals within the aggregated macrophages. Fibrosis developed in a ring shape from the periphery of the aggregated macrophages such that the starting point of fibrosis could be visualized histologically. Matrix-assisted laser desorption/ionization mass spectrometry imaging analysis detected a molecule at m/z 772.462, which corresponds to the protonated ion of phosphatidylcholine [P-18:1 (11Z)/18:0] and phosphatidylethanolamine [18:0/20:2 (11Z, 14Z)], in aggregated macrophages adjacent to the fibrotic lesions. In conclusion, the HFCC diet-fed A/J model provides an ideal tool to study fibrogenesis and enables novel insights into the pathophysiology of NASH-related fibrosis.
Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34710382     DOI: 10.1016/j.ajpath.2021.10.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  1 in total

1.  Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist.

Authors:  Brett E Phillips; Louise Lantier; Carl Engman; Yesica Garciafigueroa; Aatur Singhi; Massimo Trucco; Christos Mantzoros; David Wasserman; Nick Giannoukakis
Journal:  Cardiovasc Diabetol       Date:  2022-07-12       Impact factor: 8.949

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.